The new study, a post-hoc analysis, follows the main WARCEF study published in 2012 in the New England Journal of Medicine, finding neither aspirin nor
warfarin superior for preventing a combined risk of death, stroke, and cerebral hemorrhage in heart failure patients with normal heart rhythm.